Target intelligence / Profile preview

TATA-box binding protein associated factor 9b pseudogene 2 (TAF9BP2)

Target
TAF9BP2
Molecular classification
Other (Pseudogene)
01

Overview

TAF9BP2 (TATA-box binding protein associated factor 9b pseudogene 2) is officially described in human genomics databases as a pseudogene—a non-functional segment of DNA that resembles the functional gene for TAF9B, a protein associated with RNA polymerase II transcription initiation complexes such as TFIID[1][3][8]. As a pseudogene, TAF9BP2 is not transcribed into a functional protein, does not have recognized biological roles, is not considered a therapeutic or druggable target, and is not associated with human disease. The parent functional gene, TAF9B, encodes a bona fide factor involved in basal transcription and apoptosis[4][5], but TAF9BP2 itself does not encode a protein and is considered "dead" or non-functional in humans. Key Points: - TAF9BP2 is a pseudogene, not a functional protein-coding gene[1][3][8]. - It is incorrectly identified as a therapeutic target; it serves no role in molecular pharmacology or therapeutic intervention. - It should not be confused with TAF9B or TBP-associated factor 9b, which are related but functional genes/proteins involved in transcription initiation[1][4][5]. The presence of "pseudogene" in its canonical name and human gene annotations unequivocally indicate its non-functional status.

Other names
TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor, 31kDa pseudogene 2TAF9BP2[1][3]
02

Mechanism of action

None

03

Biological functions

None (pseudogene; no known function)
04

Disease associations

None known (not associated with any disease mechanism)
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on TATA-box binding protein associated factor 9b pseudogene 2 (TAF9BP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TATA-box binding protein associated factor 9b pseudogene 2 (TAF9BP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call